Mobiosense
Manufacturing · Taiwan · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Taipei, T'ai-pei, TaiwanWebsite
www.mobiosense.coRevenue
<$5 MillionIndustry
ZI Rank: 1
About Mobiosense
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mobiosense your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Mobiosense
Mobiosense, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Mobiosense launches new products
Check if Mobiosense has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Mobiosense is spiking on competitors!
Earning: See what the market has to say on Mobiosense recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Mobiosense has new funding data
Click to see if Mobiosense had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Mobiosense as Masked Content
Find 2 more new buyers
Mobiosense Tech Stack
A closer look at the technologies used by Mobiosense
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mobiosense
Mobiosense is a medical technology company that creates diagnostic testing equipment. They developed a COVID-19 testing kit called Cyper S, which uses isothermal nucleic acid technology. The company works with healthcare providers and medical research centers to produce accurate and fast diagnostic tools for various medical conditions.... Read More
